YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Yiviva Inc.
Yiviva Inc.
Mina Alpha Limited
National Cancer Institute (NCI)
Chinese University of Hong Kong
National Institute of Allergy and Infectious Diseases (NIAID)
GlaxoSmithKline
Seoul National University Hospital
University of California, Davis
Merck Sharp & Dohme LLC
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
University of California, Los Angeles
Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery Hospital
ANRS, Emerging Infectious Diseases
Taipei Veterans General Hospital, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
University of Oxford